Data from a population-based prospective study were used to examine longitudinal changes in blood pressure (BP) and seek interactions between apolipoprotein E (ApoE) genotypes, smoking and alcohol in a cohort of 557 elderly Brazilian men. Repeated BP measurements were obtained in four waves, and multi-level random-effects pattern-mixture models were used to evaluate agerelated BP trajectories while accounting for non-ignorable dropouts/deaths and handling heterogeneities as random parameter variations. Alcohol was associated with high systolic BP in e2 carriers and those with the e3/3 genotype, but not in e4 carriers. This was dependent on age and smoking habits: at the age of 60, expected systolic BP in alcohol drinking e2 carriers was 16.5 mm Hg higher than in the reference group of non-smokers/non-drinkers if they were not smokers (P ¼ 0.049), and 28.6 mm Hg higher if they were also smokers (P ¼ 0.004). The youngest smoking/non-drinking e2 carriers had lower systolic BP, but it increased rapidly and led to higher expected levels among older carriers. Alcohol consumption, alone or together with smoking, interacts with the effects of ApoE genotype on systolic BP, probably nullifying the more favourable lipid profile of e2 carriers. The interactions of genemodifiable risk factors have major public health implications.
INTRODUCTION
High blood pressure (BP) is a multifactorial disorder that is due to a complex interplay of a number of genetic and lifestyle factors. 1 The relationship between alcohol consumption and high BP levels is well established, particularly among men, 2 whereas the link between smoking and hypertension is still unclear. 3 Polymorphism in the ApoE gene, which encodes a plasma protein that has an important role in transporting cholesterol, has been a target for evaluating a predisposition to developing hypertension. The ApoE gene has three common alleles (e2, e3 and e4) and six different genotypes (e2/2, e2/3, e2/4, e3/3, e3/4 and e4/4). As allele e3 contributes little to variations in plasma lipids, it is believed to code for normal ApoE functions. Alleles e2 and e4 have a definite impact on lipids and lipoproteins: e2 tends to be associated with increased triglyceride levels and decreased levels of total and low-density lipoprotein cholesterol, whereas e4 is associated with increased total and low-density lipoprotein cholesterol levels. 4 The effects of ApoE polymorphism on lipids and the risk of cardiovascular disease have been extensively studied: e2 carriers are at lower risk and e4 carriers at higher risk than the carriers of the e3/3 genotype. 5 However, few studies have investigated the interactions between modifiable lifestyle factors and the effects of the ApoE genotypes. 6, 7 Findings of studies of the relationship between ApoE polymorphism and BP have been conflicting 8 and, to the best of our knowledge, only one study has examined the effects of interactions between ApoE genotypes and alcohol consumption on BP levels. 9 The Bambuì Cohort Study of Ageing is an ongoing prospective study of an elderly Brazilian cohort. As its database includes ApoE genotyping and repeated BP measurements, it offers a valuable opportunity to examine the individual longitudinal trajectories of BP levels in order to assess the interactions between ApoE genotypes and lifestyle factors, a better understanding of which could improve the development of preventive and therapeutic strategies.
In a previous study, we reported the longitudinal changes in BP levels by ApoE genotypes and explored interactions with plasma lipids and uric acid. 10 The aim of the present study was to evaluate the effects of interactions between ApoE genotypes, alcohol consumption and smoking on the age-related trends of BP levels.
MATERIALS AND METHODS

Subjects and measurements
The data come from the Bambuí Cohort Study of Ageing, which involves a population-based cohort of older adults in Bambuí, a city of approximately 15 000 inhabitants in south-eastern Brazil. The study procedures have been described in detail elsewhere. 11 Briefly, the baseline cohort population was identified by means of a complete census of the town carried out in November and December 1996. A letter was sent to all of the 1742 residents aged X60 years on 1 January 1997 to explain the study objectives and invite their participation. Of these, 1606 (92.2%, 964 women and 642 men) participated in the baseline survey, which consisted of a questionnaire covering socio-demographic, lifestyle, medical and drug use data, laboratory tests (biochemical and haematological analyses) and physical measurements (BP and anthropometric measures). The mean age 1 of the participants was 69.3 years (range 60-95). Most were white (60.4%), 33.2% were light brown ('moreno'), 3.7% dark brown ('mulato') and 2.7% black. The follow-up was based on annual interviews and reviews of medical records, and collected information concerning the current use of antihypertensive medication. ) was used. At each time point, three measurements separated by 2-min intervals were made after an initial 5-min rest, and 30 min or more after the last caffeine intake or last cigarette. The measurements were made in the early morning in a quiet, isolated, temperature-controlled room at the project field clinic by appropriately trained technicians, with the subjects seated with the arm supported at heart level. The recorded BP was the arithmetic mean of the second and third measurements.
Genomic DNA for ApoE genotyping was extracted from blood samples using the Wizard Genomic DNA Purification System (Promega, Madison, WI, USA). The DNA samples were then amplified by means of PCR, digested by HhaI, and underwent restriction-fragment length polymorphism analysis as previously described. 12 The The current use of antihypertensive drugs (AHDs) was ascertained annually by reviewing medication containers and/or physician prescriptions made during home visits to all of the participants. The medications were coded on the basis of the anatomical therapeutic chemical and defined daily dose (ATC/DDD) classification system, 13 and were considered AHDs if they fell into Anatomical Therapeutic Chemical groups C02 (antihypertensives), C03 (diuretics), C07 (beta-blockers), C08 (calcium channel blockers) or C09 (agents acting on the renin-angiotensin system). For the purposes of this analysis, the subjects using any type of AHD were considered 'treated'. The participants were divided into four groups on the basis of the number of years on treatment in relation to the number of years of follow-up: 1 ¼ untreated; 2 ¼ irregularly treated (treated for o50% of the follow-up); 3 ¼ frequently treated (X50%); and 4 ¼ regularly treated.
Current smokers were defined as those who had smoked at least 100 cigarettes during their lifetime and were still smoking; this variable was updated after three, five and eleven years of follow-up. For the alcoholconsumption estimates, the subjects were shown cards with a representation of the amount of liquid corresponding to one drink of spirits, beer or wine. Alcohol consumption was calculated by multiplying the number of drinks by the frequency of imbibing in a week during the previous 12 months. We considered two categories: 'non-drinkers' were teetotallers and ex-drinkers (those who had stopped drinking at least 12 months previously), and 'drinkers' were those currently drinking any amount of alcohol. In order to examine the separate and joint effects of alcohol consumption and smoking, we classified the subjects into four lifestyle groups: non-smokers/non-drinkers, non-smokers/drinkers, smokers/nondrinkers and smokers/drinkers.
Statistical analysis
Multi-level, random-effects pattern-mixture (MLREPM) models 14 were used to evaluate the age-related BP trajectories while accounting for nonignorable dropouts/deaths. This approach has been described in more detail in our previous paper. 10 In brief, the variable defining three groups on the basis of the pattern of their missing data (completers; lost because dropped out; and lost because of death) was included as a model covariate, and the overall estimates of the trend parameters were obtained by means of weighted averaging (mixing) the pattern-specific estimates. The weights were the estimated proportion of subjects in the three missing-pattern groups within each genotype * lifestyle group, and the s.e. of the averaged overall estimates were obtained using the delta method. In a hierarchical (multi-level) structure, AHD use constituted the third level: treatment groups, subjects within treatment group and BP measurements within subjects; and in order to avoid the problem of overparameterisation, we addressed heterogeneity in terms of random slope parameter variations across the four treatment groups. Age at baseline was included in the models to account for birth year effects, and the individual contributions to the age-related trends were spread over a single age axis ranging from 60 to 90 years. As the inclusion of quadratic age terms did not significantly improve the likelihood of the models, only linear terms were fitted. Examination of the residual plots did not show any particular trend in their distribution, thus indicating the good fitting of the models to the observed data.
As there were substantial between-gender differences in the effects of the interactions between ApoE genotype and lifestyle groups on agerelated BP trends, we here present the data relating to the men. The analyses were made using the multi-level mixed-effects linear regression (xtmixed) procedure of Stata software, version 11.2. (StataCorp LP, College Station, TX, USA) 15 
RESULTS
In all, 557 of the 642 enroled men (86.8%) underwent ApoE genotyping: 343 (61.6%) had the e3/3, 123 (22.1%) had the e3/4, 67 (12.0%) had the e2/3, 13 (2.3%) had the e4/4, 10 (1.8%) had the e2/4 and only 1 (0.2%) had the e2/2 genotype. The allele frequencies were within Hardy-Weinberg equilibrium (P40.75). The men were divided into three groups: the e3/3 group, e2 carriers (e2 þ : that is, those with the e2/2 or e2/3 genotype) and the e4 carriers (e4 þ : that is, those with the e3/4 or e4/4 genotype). The 10 subjects with the e2/4 genotype were excluded from the analysis. Of the remaining 547, 229 (41.9%) completed the followup (that is, their 2008 BP measurements were available), 75 (13.7%) were missing because they had dropped out and 243 (44.4%) had died (Table 1) . Table 2 shows some of the men's characteristics. At baseline, about 30% were smokers and about 44% were drinkers. Alcohol consumption was generally light: about 70% of the drinkers drank less than one drink per day (data not shown). The distribution of the subjects by alcohol consumption and smoking habits (P ¼ 0.706) and AHD use (P ¼ 0.479) was homogeneous across the genotype groups. Table 3 shows the MLREPM model estimates of the intercepts and slopes describing the age-related trends of systolic and diastolic BP in the three ApoE genotype goups. There was no substantial difference in the variations in systolic and diastolic BP between the genotype groups. In comparison with the e3/3 group, the expected systolic BP at the age of 60 years was lower in the e2 þ group and higher in the e4 þ group. Systolic BP increased ApoE genotypes,alcohol,smoking and blood pressure MLC Leite et al faster in the e2 þ group, but no systolic slope was significantly different from zero. At the age of 60 years, diastolic BP was an average of about 90 mm Hg, and decreased significantly by a mean of 0.45 mm Hg with each year of age. We then investigated the data for heterogeneities in the BP trends by examining the separate and the joint influence of alcohol consumption and smoking. Figures 1-3 show the agerelated trends of systolic and diastolic BP for each ApoE genotype group estimated from the MLREPM model, stratified on the basis of alcohol and smoking habits. Figure 4 shows the results of pooled analysis of all ApoE genotypes. By taking the non-drinkers/ non-smokers as the reference group, the younger drinkers in the e2 þ group had higher systolic BP: at the age of 60 years, their expected systolic BP was 16.5 mm Hg higher than the 123.2 mm Hg estimated in the reference group if they did not smoke (P ¼ 0.049) and 28.6 mm Hg higher if they did (P ¼ 0.004) (Figure 1 ). These differences disappeared in the older subjects because systolic BP in the reference group increased by 0.70 mm Hg for each year of age (P ¼ 0.094). The younger smokers/nondrinkers had lower systolic BP, but their estimated slope was 2.92 mm Hg (P ¼ 0.055), leading to espected higher systolic BP in the older age groups. Regardless of their smoking habits, younger drinkers had higher diastolic BP, but the differences were not significant.
The pattern was different in the e3/3 genotype group (Figure 2 ). Alcohol consumption was associated with higher systolic BP in the younger age groups if it was accompanied by smoking: at the age of 60 years, the expected systolic BP was 12.5 mm Hg higher than the estimated 137.7 mm Hg in the reference group (P ¼ 0.013). The non-smoking drinkers had lower systolic BP at the age of 60 years (P ¼ 0.062), but their BP levels increased more rapidly; the slope of 0.59 mm Hg per year of age (P ¼ 0.033) was significantly higher than that close to zero of the reference group (P ¼ 0.009). In the same e3/3 genotype group, the younger drinking smokers also had higher diastolic BP, particularly when compared with the estimated value in the group of non-drinking smokers (P ¼ 0.002).
In the e4 þ group, there were no significant differences in the age-related trends of systolic and diastolic BP between the lifestyle groups ( Figure 3 ).
DISCUSSION
We examined our data in order to determine the effects of interactions between ApoE polymorphism and smoking and/or alcohol consumption on the longitudinal trends of BP levels, and found that these habits affected the age-related patterns of variation in systolic BP differently in the groups defined on the basis of the presence of ApoE alleles.
The strength of our study mainly lies in its prospective design, which is the appropriate means of investigating geneenvironmental interactions in complex human diseases. 16 We constructed a complex statistical model to evaluate the Abbreviation: BP, blood pressure. e2 þ (e2/2, e2/3); e4 þ (e3/4, e4/4). subject-specific BP trajectories accounting for informative (nonignorable) 'missingness'. On the other hand, unlike the smoking data (which were updated during follow-up), only baseline data were available concerning alcohol consumption; the related estimates could therefore be subject to dilution bias which, however, is known to be toward null and underestimates the real association. 17 Although we followed a large number of subjects for a long time, the analysis was limited by intrinsic imbalances and a lack of statistical power due to the small size of some groups. Moreover, the genotype subgroups were not large enough to further stratify by levels of alcohol consumption. Then, we did not perform dose-response analysis.
Most of our elderly men were light-to-moderate drinkers. However, we cannot exclude some degree of underreporting. Heavy drinkers have consistently been found to have higher BP levels, but the relationship between light-to-moderate alcohol consumption and hypertension remains controversial. 18 A large prospective study found that light-to-moderate alcohol consumption decreased hypertension risk in women and increased risk in men. 19 We found that alcohol consumption was associated with high systolic BP, particularly in the younger age groups of the e2 carriers and, to a lesser extent, in the older age groups of the subjects with the e3/3 genotype. Our results are in line with those of the only other study we know, which found that an interaction between ApoE polymorphism and alcohol consumption increased the BP of middle-aged men, with those carrying the e2 allele being particularly susceptible. 9 Like us, they found a significant association between systolic BP and alcohol consumption in men with the e2/3 and e3/3 genotypes, but not in those with the e4/3 genotype.
The mechanism by which the e2 allele interacts with alcohol is unclear, but it is possible that the two factors have adverse effects on the metabolism of triglycerides that synergistically contribute to increasing their circulating levels, a disorder that is associated with arterial stiffness in men. 20 Both the e2 allele 21 and alcohol consumption by men 22 delay triglyceride-rich lipoprotein clearance. Furthermore, it has been found that the use of moderate amounts of alcohol significantly exacerbates preexisting hypertriglyceridemia, 23 and it is possible that the e2 carriers are particularly susceptible to the inhibitory effect of alcohol on lipoprotein lipase activity. 24 An increase in post-prandial lipidemia is an interesting hypothesis linking the e2 allele and alcohol consumption to hypertension. The presence of the e2 allele predisposes to the post-prandial accumulation of remnant particles, 21 and alcohol increases postprandial lipidemia in inactive men, 22 particularly when accompainied by a meal containing fat. 24 It has been found that post-prandial, triglyceride-rich remnant particles impair arterial compliance 25 and directly influence endothelial function, 26 and so they may induce atherogenesis and hypertension by activating inflammatory and/or oxidative stress pathways.
Combined alcohol consumption and smoking was associated with even higher levels of systolic BP in the e2 þ group, and with early hypertension in the group with the e3/3 genotype. It is possible that smoking acts by strengthening the effect of alcohol because it has been found to be associated with a significantly increased post-prandial triglyceride response, probably as a result of the downregulation of lipid-metabolising enzymes. 27 With regard to the separate effect of smoking on the agerelated trends of systolic BP, we observed a particular pattern of variation in the e2 þ group. Although their slope was not significantly different from that of the reference group, the systolic BP levels of the smokers/non-drinkers increased very rapidly: the youngest age groups had the lowest levels and the oldest age groups had the highest levels. It has been hypothesised that the effect of smoking on BP is due to an initial vasoconstricion mediated by nicotine followed by a decrease in BP caused by the depressant effects of chronic nicotine administration; on the other hand, carbon monoxide acts directly on the arterial wall inducing, in the long run, irreversible structural alterations that lead to a later increase in BP levels. 28 The pattern that we observed in the smoking/non-drinking e2 carriers is consistent with this hypothesis, although it is not clear why e2 carriers may be more susceptible to the injurious effects of smoking. However, there is evidence showing that some components of circulating triglyceride-rich lipoprotein impair endothelial nitric oxide production, 29 and disordered nitric oxide metabolism is associated with increased arterial stiffness, but only in the presence of current smoking. 30 The grouping of the six genotypes is a methodological aspect of a study such as this. The relatively rare e2/4 genotype seems to characterise a special group of subjects and, given the presumed opposite effects of their alleles, they are often excluded from Figure 5 . Estimated age-related trends of systolic and diastolic BP in the e2 þ * (e2/2,e2/3,e2/4) and e4 þ * (e3/4,e4/4,e2/4) genotype groups, stratified on the basis of smoking and alcohol drinking habits.
analyses. However, they are sometimes included among the e2 carriers 31 and sometime among the e4 carriers. 32 Consequently, and for sensitivity purposes, we made two analyses: one in which the 10 men with the e2/4 genotype were included in the e2 þ group, and another in which they were included in the e4 þ group (see Figure 5) . The impact was minimal in the e4 þ group, but in the e2 þ group, the effect of smoking was more marked: among the smokers/non-drinkers, systolic BP increased with age at a faster rate (slope ¼ 3.01, P ¼ 0.028), but it also increased among the smokers/drinkers (this slope was originally slightly negative). It has been shown that the e2 allele is dominant and has a greater impact than the e4 allele, 33 and so it seemed preferable to include the e2/4 subjects in the e2 þ group. By doing so, the deleterious effect of alcohol consumption (regardless of smoking) on systolic BP in our male e2 carriers aged o75 years, and that of smoking (regardless of drinking) in the older subjects, emerged even more clearly.
Taking our results together with those of previous studies leads us to hypothesise that e2 carriers who drink alcohol may form a group at particular risk of haemorrhagic stroke, for which the risk factors include hypertension, 34 alcohol consumption 35 and the presence of the e2 allele. 36 In conclusion, we found that interactions between the ApoE genotype and alcohol consumption (alone or combined with smoking) affects the levels of systolic BP. The greater effect of alcohol on BP in middle-aged e2 þ men is due to the fact that non-drinking e2 carriers have lower systolic BP levels than e3/3 and e4 þ carriers (there was little difference in systolic BP levels between the drinkers in the e2 þ and the e4 þ groups). We hypothesise that alcohol consumption nullifies the 'protective effect' of the e2 allele, which is mediated by its more favourable lipid profile. 37 Smoking and drinking are modifiable habits, which underlines the public health implications of these geneenvironmental interactions. Our findings suggest that e2 þ men group and the more numerous e3/3 group may particularly benefit from a change towards healthier habits.
What is known about this topic
Alcohol consumption is associated with high BP levels, whereas the link between smoking and hypertension remains unclear.
The findings of studies of the relationships between ApoE genotypes and BP have been conflicting, and it is still not known whether interactions between ApoE polymorphism and smoking and/or alcohol consumption affect BP levels.
What this study adds
In elderly men, alcohol consumption and smoking influence the agerelated patterns of BP variations differently in groups defined on the basis of ApoE alleles. Younger e2 carriers seem to be particularly susceptible to the effect of alcohol consumption on systolic BP, and older e2 carriers seem to be particularly susceptible to the effect of smoking. In older carriers of the e3/3 genotype, alcohol consumption is associated with high systolic BP; this is only true of younger carriers if combined with smoking. In the e4 þ group, there was no significant difference in the agerelated trends of BP between the lifestyle groups. Our results suggest that elderly men in the e2 þ group and the more numerous e3/3 group may obtain a particular benefit by changing to a healthier lifestyle.
